Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year Ending	Current	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	86	7	9	33	10	10
Market Cap Growth	131.73%	-29.60%	-71.60%	228.38%	5.62%	-52.85%
Enterprise Value	77	5	6	14	1	-6
PE Ratio	-	-0.34	-0.52	-2.40	-1.23	3.69
PS Ratio	12338.31	88.98	129.85	565.78	99.66	0.79
PB Ratio	11.24	33.04	3.29	1.67	0.99	0.58
P/FCF Ratio	-0.67	-0.37	-0.60	-2.56	-1.33	2.19
P/OCF Ratio	-0.67	-0.37	-0.60	-2.60	-1.35	2.01
EV/Sales Ratio	11018.03	62.90	84.78	233.92	7.46	-0.50
EV/EBITDA Ratio	0.01	-0.25	-0.35	-1.03	-0.10	-2.21
EV/EBIT Ratio	0.01	-0.24	-0.34	-0.99	-0.09	-2.34
EV/FCF Ratio	0.01	-0.26	-0.39	-1.06	-0.10	-1.39
Debt / Equity Ratio	0.03	2.77	0.28	0.01	0.04	-
Debt / EBITDA Ratio	-0.02	-0.03	-0.05	-0.02	-0.05	-
Debt / FCF Ratio	-0.02	-0.03	-0.05	-0.02	-0.05	-
Quick Ratio	4.14	0.65	1.62	14.48	8.69	6.92
Current Ratio	4.18	0.94	1.90	15.05	9.52	7.10
Asset Turnover	0	0.01	0.01	0.00	0.01	0.72
Interest Coverage	-902.83	-591.79	-568.00	-2312.67	-	-
Return on Equity (ROE)	-175.40%	-274.30%	-198.40%	-104.20%	-61.70%	17.60%
Return on Assets (ROA)	-127.80%	-183.20%	-152.10%	-93.70%	-53.70%	15.30%
Return on Capital (ROIC)	-181.31%	-2507.36%	-483.46%	-67.23%	-77.81%	15.57%
Earnings Yield	-25.12%	-293.13%	-192.08%	-41.59%	-81.39%	27.11%
FCF Yield	-15.78%	-269.92%	-167.86%	-39.10%	-75.05%	45.61%
Buyback Yield / Dilution	-58.95%	-188.30%	-90.24%	-320.63%	-19.19%	16.47%
Total Shareholder Return	-58.95%	-188.30%	-90.24%	-320.63%	-19.19%	16.47%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).